Skip to main content

Table 7 Frequency of HCV recurrence among CRS categories; donor steatosis groups. CRS subgroups are high risk, CRS > 0.7; moderate risk, CRS 0.5–0.7; low risk, CRS < 0.5

From: Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation

  Liver transplanted patients P value
HCV recurrence Non-recurrence
Count % Count %
CRS SCORE Low risk 10 33.3% 15 34.1% 0.943
Moderate risk 12 40.0% 16 36.4%
High risk 8 26.7% 13 29.5%
Donor steatosis % Low<3.5 12 38.7% 39 81.3% <0.001
High>3.5 19 61.3% 9 18.8%